Workflow
Citizens Holding(CIZN)
icon
Search documents
Snow Appointed to First Citizens BancShares Board of Directors
Prnewswire· 2024-12-16 21:32
RALEIGH, N.C., Dec. 16, 2024 /PRNewswire/ -- Matt Snow has been appointed to the board of directors of First Citizens BancShares, Inc. ("BancShares") and its subsidiary, First-Citizens Bank & Trust Company ("First Citizens Bank"), effective Jan. 2, 2025. Matt Snow has been appointed to the board of directors of First Citizens BancShares, Inc. and its subsidiary, First-Citizens Bank & Trust Company, effective Jan. 2, 2025. For the past two years, Snow has served as chairman of the governing board of For ...
Citizens, Inc. Announces Filing of Form S-3 to Replace Expiring Shelf Registration Statement
Newsfile· 2024-11-27 21:05
Citizens, Inc. Announces Filing of Form S-3 to Replace Expiring Shelf Registration StatementNovember 27, 2024 4:05 PM EST | Source: Citizens, Inc.Austin, Texas--(Newsfile Corp. - November 27, 2024) - Citizens, Inc. (NYSE: CIA), a leading diversified financial services company specializing in life, living benefits, and final expense insurance, today announced it has filed a shelf registration statement (the "Shelf Registration") on Form S-3 with the United States Securities and Exchange Commiss ...
Prelude Therapeutics to Participate in Citizens JMP Securities Hematology and Oncology Summit
GlobeNewswire News Room· 2024-11-27 12:30
WILMINGTON, Del., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens JMP Securities Hematology and Oncology Summit, taking place virtually on December 2, 2024. On Monday, December 2, at 11:30 a.m. ET, Kris Vaddi, Ph.D., Chief Executive Officer of Prelude, and Jane Huang, M.D., President and Chief Medical Officer, will participate in a fireside chat. A live ...
Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit
GlobeNewswire News Room· 2024-11-26 16:00
HOUSTON, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that Juan Vera, M.D., President and Chief Executive Officer of Marker Therapeutics, will present at the Citizens JMP Hematology and Oncology Summit. This investor event will be held virtually on December 2, 2024. Dr. Vera wil ...
Pivot Energy Secures Over $450 Million in Major Financing of Distributed Generation Portfolios from First Citizens, ATLAS SP, and HASI
Prnewswire· 2024-11-21 12:30
The debt warehouse facility and structured equity investment will support construction of 300 Megawatts of U.S. community solar projects and is Pivot's largest financing agreement to dateDENVER, Nov. 21, 2024 /PRNewswire/ -- Pivot Energy ("Pivot"), a leading, national renewable energy provider and independent power producer, announced today two transformational financing arrangements, marking a critical step toward establishing innovative and scalable financing facilities. Pivot has successfully secured a $ ...
Citizens, Inc. Reports Third Quarter 2024 Financial Results
Newsfile· 2024-11-07 21:05
Austin, Texas--(Newsfile Corp. - November 7, 2024) - Citizens, Inc. (NYSE: CIA), a leading diversified financial services company specializing in life, living benefits and final expense insurance, today reported results for the third quarter ended September 30, 2024."We are thrilled to report strong sales momentum and exceptional execution in the third quarter and throughout 2024 with several significant developments. Our strategic roadmap is designed to deliver improved operating results and sustainable g ...
Tradepulse Power Inflow Alert: First Citizens Bancshares Inc. Rises Over 100 Points After Signal
Benzinga· 2024-11-07 00:51
STOCK MOVES UP OVER 4% ON DAYFirst Citizens BancShares, Inc. FCNCA today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions. Today, at 10:00 AM on November 6th, a significant trading signal occurred for First Citizens BancShares, Inc. as it demonstrated a Power Inflow at a price of $2171.52. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" move ...
First Citizens Bank Offering Tax Equity Investments in Renewable Energy Projects
Prnewswire· 2024-10-29 14:00
NEW YORK, Oct. 29, 2024 /PRNewswire/ -- First Citizens Bank today announced that its Energy Finance business is introducing a new tax equity investment product to help finance renewable energy projects. Tax equity products enable qualified investors to reap the benefits of various tax incentives aimed at promoting the development of renewable energy. As an industry leader in renewable energy financing, First Citizens Energy Finance is well positioned to expand its product capabilities, which will now includ ...
First Citizens BancShares: One Of The Banks To Own In A Potential Trump Presidency
Seeking Alpha· 2024-10-29 11:10
Economist with 10-year experience doing sell-side research on euro-area and emerging market economies. My credo is that doing your homework is essential when investing and seeing as many viewpoints as possible can only help you make better investment decisions. I hope I can do my part to guide you through the markets!I have passed the CFA Level 3 exam. I have a Bachelor's Degree in Economics. Disclaimer: I DO NOT provide financial advice. All opinions expressed on financial instruments are my own and may no ...
Citizens Community Bancorp, Inc. Reports Third Quarter 2024 Earnings of $0.32 Per Share; Nine Month 2024 Earnings of $1.07 Per Share
GlobeNewswire News Room· 2024-10-28 12:30
EAU CLAIRE, Wis., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Citizens Community Bancorp, Inc. (the "Company") (Nasdaq: CZWI), the parent company of Citizens Community Federal N.A. (the "Bank" or "CCFBank"), today reported earnings of $3.3 million and earnings per diluted share of $0.32 for the third quarter ended September 30, 2024, compared to $3.7 million and earnings per diluted share of $0.35 for the quarter ended June 30, 2024, and $2.5 million and $0.24 earnings per diluted share for the quarter ended Septembe ...